medicine 16 (e.g., clinical use of cisplatinum compounds), thus encouraging chemists to design new metallated anticancer agents. Several examples of metallated curcuminoid analogues, which all involve the coordination of the metal to the oxygens of the β-diketone, have been evaluated for their biological properties. [17] [18] [19] [20] [21] [22] [23] [24] [25] Because there were no published reports of an organometallic moiety covalently grafted to curcumin or its derivatives, we recently described the synthesis of the first examples of such ferrocenyl derivatives 5, 6 and 7 ( Figure 1 ). 26 We therefore became interested to further investigate the covalent anchorage of a ferrocenyl unit to several curcuminoids. We hypothesized that the presence of ferrocene in curcumin derivatives could enhance the biological activity against cancer cells, as we previously reported for ferrocenyl derivatives of steroidal antiandrogens 27 and of the antioestrogen tamoxifen. 28, 29 In the present report, we synthesized eight novel ferrocenyl curcuminoids in order to evaluate some of their biological properties. To do so, three different ferrocenyl spacer chains were chosen to be anchored to the central carbon of the curcuminoid skeleton: ferrocenyl propenone to increase the conjugation up to the ferrocenyl (series A), ferrocenyl methylene forcing the β-diketone to be in its diketone tautomer form (series B), and ferrocenyl ethanone interrupting the conjugation between the skeleton and the ferrocenyl moiety (series C). The effect of the substitution by a methoxyl instead of an hydroxyl on the two phenyl groups was also investigated by choosing dimethylcurcumin 2, 3,5-dimethoxycurcumin 3 and trimethoxycurcumin 4 ( Figure 1 ) as curcuminoid skeleton, in addition to curcumin. Although 3 and 4 have already been reported in the literature, 30 they have not been studied in details.
We report here the synthesis of several ferrocenyl derivatives of the curcuminoids 1, 2, 3 and 4. We also tested these ferrocenyl derivatives for some important biological activities required for anticancer activity, i.e., their cytotoxicity against murine B16 melanoma cells and NIH 3T3 normal cells, their effect on the inhibition of tubulin polymerization and the analysis of the morphological effects on endothelial cells (as a model of antitumor antivascular effect). 31 For comparison purposes, curcumin and compounds 2, 3 and 4 also underwent these biological tests.
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Synthesis of curcuminoid ferrocenyl derivatives
The curcuminoids 1, 2, 3 and 4 ( Figure 1 ) were synthesized following Pederson's conditions 32 by condensing an appropriate aldehyde with 2,4-pentanedione in the presence of a base as well as tributylborate and boric anhydride. The latter is required to complex the 2,4-dione moiety in order to prevent a Knoevenagel condensation on C-3. It was shown that the β-diketone of curcumin exists as keto-enol tautomer in solid state, 33 as well as in solution, 34 as observed for the three other curcuminoids (2, 3 and 4).
We previously reported the synthesis of compound 5 bearing a ferrocenyl propenone moiety (Scheme 1), obtained from 3,5-dimethoxycurcumin 3. 26 Following the same procedure, dimethylcurcumin and trimethoxycurcumin analogues 8 and 9 were also successfully synthesized. The enol of 2 and 4 was deprotonated by stirring in the presence of sodium hydride for 2 hours at room temperature. Ferrocenyl propynone 35 was then added to produce 8 and 9 with yields of 25 and 14%, respectively. The rather modest yields obtained, also observed previously for 5 were explained by the degradation of the starting material if the reaction time was prolonged. 1 H NMR spectra of 8 and 9 were similar to that of 5 and showed that the peak at 5.85 ppm, corresponding to the central proton of the β-diketone in its keto-enol form, had disappeared and confirmed that the substitution took place at the desired C-4 position. The crystal structure of 5 has previously been reported. 26 In order to force the β-diketone of the curcuminoid to stay in its diketo form instead of the keto-enol form, the organic curcuminoids 1, 2, 3 and 4 underwent a Knoevenagel condensation with ferrocenecarboxaldehyde to form 10, 11, 12 and 13, respectively, following a modified procedure reported for the substitution of organic species (Scheme 2). 36 In our case, ferrocenecarboxaldehyde was condensed to the corresponding organic curcuminoid in the presence of freshly distilled piperidine in anhydrous DMF instead of a CHCl 3 / EtOH solution, in order to increase the yields of the newly formed ferrocenyl curcuminoids, e.g., from 3% to 27% for 11. Again, moderate yields (22-28%) were obtained because of degradation with longer reaction times. Confirmation of the desired substitution was obtained by confirmed by the appearance of a second carbonyl peak on the 13 C NMR spectrum. It is noteworthy that these conditions of Knoevenagel condensation did not require prior protection of the phenol groups of curcumin, therefore enabling us to prepare 10 in one step.
With the purpose of studying the effect of an interruption of the conjugation between the curcuminoid and the ferrocenyl, a ferrocenyl ethanone moiety was therefore grafted to dimethylcurcumin 2 and a protected curcumin, 14 (Scheme 3). Indeed, for this reaction, it was necessary to protect the phenols of curcumin. We previously described a modified synthesis of a bis-tetrahydropyran (14) and bis-tbutyldimethylsilyl curcumin 26 and discussed the relative stability of ferrocenyl protected curcumin towards the different conditions of deprotection for a THP and a TBDMS group. For this reaction, the protection by a THP moiety was chosen because deprotection occurs in milder conditions than for TBDMS. Compounds 2 and 14 were deprotonated by sodium hydride in the same conditions as described above, before α-bromoacetylferrocene 37 (obtained from ferrocene and 2-bromoacetyl bromide) was added dropwise. After heating for 4 hours and then stirring overnight at room temperature, 15 and 16 were formed in approximately 50% yield. The reaction has also been carried out using α-chloroacetylferrocene, but 15 was obtained in only 17% yield while 16 could not be formed. The NMR spectra of 15 and 16 showed that the β-diketones were in their diketo-rather that their keto-enol forms . Indeed, in their 1 H NMR spectra, the H-4 singlet of the keto-enol form at 5.85 ppm disappeared, while a triplet at 4.95 ppm was observed, attributed to the H-4 of the diketo form. Additionally, one peak at 195 ppm, corresponding to the two symmetrical carbonyl groups of the curcuminoid skeleton, was observed in their 13 C NMR spectra. Similar observations were reported by Pederson for the synthesis of several substituted organic curcuminoids. 32 For example, the synthesis consisting in the alkylation of curcumin on the central carbon (C-4) with benzyl bromide only led to the tautomer in its diketo form.
In order to obtain the curcumin ferrocenyl ethanone derivative, the deprotection of the THP protecting groups of 16 was carried out by using pyridinium p-toluenesulfonate (PPTS) in CH 2 Cl 2 / EtOH to lead to the formation of the desired unprotected ferrocenyl curcumin 17 in 68% yield, confirming the stability inserm-00709892, version 1 -19 Jun 2012
of ferrocenyl ethanone curcuminoids under mild acidic conditions. The NMR spectra of 17 showed that the β-diketone is in the same diketo form as for the protected derivative 16.
Biological evaluation of the ferrocenyl derivatives of curcumin
The synthesized ferrocenyl curcuminoid derivatives were evaluated in vitro for some biological properties frequently linked to anticancer activity, i.e., for their cytotoxicity against murine B16 melanoma cells and NIH 3T3 normal cells, their effect on tubulin polymerization, and their induction of a rapid morphological change of endothelial cells (rounding up) that may hint to a possible antivascular effect. For comparison purposes, the organic compounds 1, 2, 3 and 4 were also tested in parallel, as well as combretastatin A4 (CA-4), a well-known vascular disrupting agent.
38
Cytotoxicity
The murine B16 melanoma cells were chosen to evaluate the cytotoxicity because melanoma is particularly refractory to chemotherapy. Of the three organic curcuminoids evaluated for the first time in this study on B16 cells, it was of interest to note that trimethoxycurcumin 4 exhibited higher cytotoxic activity (IC 50 = 2.8 µM) compared to 1, 2 and 3 (IC 50 values comprised between 8.5 and 12.0 µM). Looking at the substitution of the aromatic rings, it appears that the absence of substituent at the para position decreases somewhat the cytotoxic activity of the resulting curcuminoid, because 3,5-dimethoxycurcumin 3 showed the least cytotoxic effect with an IC 50 value of 12.0 µM.
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The two ferrocenyl unsymmetrical compounds 6 and 7, as well as the ones of the series A (5, 8, and 9), were shown to be weakly cytotoxic. However, the four ferrocenyl derivatives of series B (containing a ferrocenyl methylene chain) presented the most cytotoxic activity of our compounds with IC 50 values ranging from 2.2 µM for 13 to 7.1 µM for 11. For the dimethylcurcumin and trimethoxycurcumin analogues (11 and 13), the ferrocenylation did not significantly improve the cytotoxic activity. However,
we observed an interesting two-fold increase in cytotoxicity for the ferrocenyl analogues of 1 and 3, i.e., 10 and 12. Representative curves showing the decrease in number of viable cells upon treatment with increasing concentrations of the organic 3,5-dimethoxycurcumin 3 and its ferrocenyl analogue 12 is depicted in Figure 2 .
As a result, in the B16 cellular model, the diketo form of the ferrocenyl derivatives, as well as conjugation up to the ferrocenyl (series B), seemed required for high cytotoxic activity. In series C, 15
and 17, which are also in diketo form, but have disrupted conjugation, did not exhibit increased cytotoxicity compared to their corresponding organic curcuminoids. Indeed, similar IC 50 values were obtained for 15 and dimethylcurcumin 2, while the cytotoxic activity of 17 decreased dramatically compared to curcumin 1 (75.7 vs 8.5 µM, respectively).
Although not in the same chemical series, our compounds were compared to combretastatin A4 which is considered as a standard antivascular agent. All the curcuminoid analogues were less cytotoxic to B16 melanoma cells compared to combretastatin A4. For example, the best cytotoxic curcuminoid analogue 13 (IC 50 =2.2 µM) was about 700-fold less cytotoxic compared to combretastatin A4 (IC 50 =0.003 µM)
For comparison purposes, we also evaluated the cytotoxic activity of these compounds against the NIH 3T3 normal cell line. Table 1 shows that the IC 50 of the normal cells were higher than the IC 50 for the cancer cells (B16 melanoma) for most compounds (with the exception of 17). This could indicate an interesting selectivity of cytotoxic action against cancer cells compared to normal ones, as previously observed for other curcuminoids (reviewed in reference 40-b).
Inhibition of tubulin polymerization (ITP a )
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We were also interested to test our curcumin ferrocenyl derivatives on tubulin polymerization, because several potent clinically used anticancer drugs are indeed known to act on tubulin dynamics 41, 42 (e.g., vinca alkaloids, taxanes), and because it was recently reported that curcumin could also inhibit microtubule assembly.
11
In our assay conditions, curcumin was shown to inhibit microtubule formation with an IC 50 value of 17.9 µM (Table 1) . Our data corroborate Gupta and coworkers' observations, although their reported IC 50 value is higher than ours (calculated IC 50 ≈ 80 µM). 11 A plausible explanation for our lower IC 50 value is likely due, in our case, to a preincubation period of 45 minutes at room temperature in presence of the tested compound, which allows for the tested ligand to more closely interact with tubulin prior to the beginning of the polymerization with the addition of guanosine triphosphate (GTP) and incubation at 37 °C. The function of this preincubation step is to maximize the potential for detecting the interaction of drugs with tubulin, and to give a better idea of the relative potency of slow-binding agents (such as colchicinoids), both in comparison with each other, and in comparison with other classes of drugs. 43 Of the organic curcuminoids, only curcumin presented an IC 50 value of less that 30 µM.
Within the series of the ferrocenyl curcuminoids, the unsymmetrical compound 6 was not markedly active on tubulin polymerization, whereas its isomer 7 presented an IC 50 value of 9.3 µM.
Although the high activity of combretastatin CA-4 could not be reached by the symmetrical organometallic compounds, the presence of a ferrocenyl moiety was generally linked to a marked increase in tubulin inhibition activity compared to their organic counterparts, with the exception of curcumin substituted with ferrocenyl methylene moiety 10, which showed a similar ITP activity.
The lowest IC 50 values (2.1 to 5.8 µM) were observed with the ferrocenyl propenone curcuminoids of the ferrocenyl curcuminoids (dimethylcurcumin derivatives 8, 11 and 15) produced the best antitubulin activity (2.5 -5.5 µM), whatever the spacer chain used.
Morphological effects on endothelial cells
Because several antitumor antivascular compounds act on endothelial cells, we also tested the morphological effects of our novel ferrocenyl compounds on immortalized HUVEC (Ea.hy 926), as a model of potential antitumor antivascular effect. 31, 38 A rounding up effect of endothelial cells was observed only at high concentrations (50-100 µM) for the organic curcuminoids ( Table 1 ). The introduction of the ferrocenyl allowed the morphological rounding up to occur at significantly lower concentrations for all series A, B and C. In the series A, the concentration needed for rounding up was 12.5 µM. For series B, with the exception of the dimethylcurcumin 2 and 3,5-dimethoxycurcumin 3 analogues (11 and 12) , a significant decrease in the concentration needed for rounding up of endothelial cells was noted, as well as in series C (25 µM).
These data clearly indicate that the presence of a ferrocenyl moiety could significantly lower the concentration needed for the rounding up of endothelial cells for the majority of our symmetrical ferrocenyl curcuminoids. Figure 3 shows a representative change in endothelial cells shape for compound 13 (series B) at 6.3 µM.
In addition, the increase in morphological activity of these curcuminoid analogues appeared to be correlated with their antitubulin activity. As a matter of fact, we observed a statistically significant linear correlation between the ITP values (x) and the concentration needed for rounding up (y), indicating that the best ITP values were linked to a lower concentration for morphological activity (y=1.81x+13.71, R=0.661, P<0.007).
Conclusion
In this work, eight novel ferrocenyl curcuminoids were synthesized by covalent anchorage of three 
